SEHK Hosts Two PE-backed BioTech Plays
13 May 2026
US$ 20.00
IMPACT Therapeutics Inc (IMPACT), an oncology drug company backed by Lilly Asia Ventures (LAV) and Decheng Capital ......
Related Publications
Subscribers’ Weekly for the week ending 11 Sep 2026...
For more than 18 months Homeplus Co Ltd (Homeplus), South Korea’s second-largest supermarket chain that is ......
Connect With Us
We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.
Rest assured that your email address will not be shared, as we hate spams as much as you do.